Pursuant to Regulation 30 & 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Choksi Laboratories has informed that it enclosed the following: Considered and approved Unaudited Financial Results along with Limited Review Reports for the Quarter and Half Year ended on 30th September, 2025. The aforesaid results are duly approved by the Audit Committee and Board of Directors in their respective meetings held on Friday, 14th November 2025.
The above information is a part of company’s filings submitted to BSE.
